Alprostadil combined with pioglitazone in treatment of diabetic nephropathy and relative inflammation factors

CLINICAL FOCUS ›› 2011, Vol. 26 ›› Issue (5): 395-397.

Previous Articles Next Articles

Alprostadil combined with pioglitazone in treatment of diabetic nephropathy and relative inflammation factors

XING Xi-zhi;SUN Zhi-fen;SHAO Peng;WANG Yan-min;LIU Xing-wang

Online:2011-03-05 Published:2011-03-05

Abstract

CLC Number:

R587.2

XING Xi-zhi;SUN Zhi-fen;SHAO Peng;WANG Yan-min;LIU Xing-wang. Alprostadil combined with pioglitazone in treatment of diabetic nephropathy and relative inflammation factors[J]. CLINICAL FOCUS, 2011, 26(5): 395-397.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2011/V26/I5/395

[1]	Zhang Xinxin, Liu Guoqing, Wang Beibei. Extreme thrombocytosis caused by diabetic ketoacidosis: A case report and literature review [J]. Clinical Focus, 2023, 38(8): 719-721.
[2]	. [J]. Clinical Focus, 2023, 38(6): 564-568.
[3]	. [J]. Clinical Focus, 2023, 38(6): 569-572.
[4]	. [J]. Clinical Focus, 2023, 38(4): 364-368.
[5]	Li Huifang, Miao Xia. Prediction of thyroid hormone level on risk of type 2 diabetes nephropathy [J]. Clinical Focus, 2023, 38(2): 137-142.
[6]	Ju Yan, Guo Peng, Wu Botao, Liu Xinyu. Correlation between ratio of salivary uric acid to blood uric acid and diabetic peripheral neuropathy [J]. Clinical Focus, 2023, 38(1): 37-41.
[7]	He Feng, Nin Lu, Luo Gao, Yang Ruifei, Li Fanfan, Cheng Xiaoqiong, An Binbin, Li Jingjuan, Liu Yuanyuan, Guo Qian, Wang Jinyang. Correlation of Chinese visceral adipose index and visceral fat area with diabetic nephropathy and their warning values [J]. Clinical Focus, 2022, 37(12): 1089-1093.
[8]	. [J]. Clinical Focus, 2022, 37(12): 1148-1152.
[9]	Yao Yao, Chu Min. Relationship between serum amyloid β-protein and cognitive dysfunction in patients with diabetic kidney disease [J]. Clinical Focus, 2022, 37(9): 813-816.
[10]	. [J]. Clinical Focus, 2022, 37(5): 467-471.
[11]	Gao Shixin, Song Bing, Shi Kexin. Diagnosis value of serum lipoprotein α, cystatin-C and uric acid on early diabetic nephropathy [J]. Clinical Focus, 2022, 37(3): 248-252.
[12]	Wang Desheng, Sun Zhigang, Ma Zhoupeng. Correlation of serum high-sensitivity C-reactive protein and urine microalbumin/creatinine and retinal lesions in diabetic [J]. Clinical Focus, 2022, 37(3): 253-256.
[13]	. [J]. Clinical Focus, 2022, 37(2): 178-181.
[14]	Liu Lunzhi, Deng Lu, Zhang Mingxia. Effects of angiotensin Ⅱ type 1 receptor blockers on urinary nephrin and Beclin-1 mRNA excretion in urine of patients with early diabetic nephropathy [J]. Clinical Focus, 2021, 36(11): 1005-1008.
[15]	. [J]. Clinical Focus, 2021, 36(11): 1029-1033.

Alprostadil combined with pioglitazone in treatment of diabetic nephropathy and relative inflammation factors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments